drugset / Trial / NCT00432263

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.

NCT00432263

Phase 4 Withdrawn Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To establish the effects of genotropin replacement in patients with severe growth hormone deficiency after traumatic brain injury on cognitive function.

Timeline

Start
2007-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic